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A growing body of literature has suggested that intranasal oxytocin (OT) or other systemic 
routes of administration can alter prosocial behavior, presumably by directly activating OT 
sensitive neural circuits in the brain. Yet there is no clear evidence that OT given periph-
erally can cross the blood–brain barrier at levels sufficient to engage the OT receptor. 
To address this issue we examined changes in blood oxygen level-dependent (BOLD) 
signal intensity in response to peripheral OT injections (0.1, 0.5, or 2.5 mg/kg) during 
functional magnetic resonance imaging (fMRI) in awake rats imaged at 7.0 T. These data 
were compared to OT (1 μg/5 μl) given directly to the brain via the lateral cerebroventricle. 
Using a 3D annotated MRI atlas of the rat brain segmented into 171 brain areas and 
computational analysis, we reconstructed the distributed integrated neural circuits iden-
tified with BOLD fMRI following central and peripheral OT. Both routes of administration 
caused significant changes in BOLD signal within the first 10 min of administration. As 
expected, central OT activated a majority of brain areas known to express a high density 
of OT receptors, e.g., lateral septum, subiculum, shell of the accumbens, bed nucleus 
of the stria terminalis. This profile of activation was not matched by peripheral OT. The 
change in BOLD signal to peripheral OT did not show any discernible dose–response. 
Interestingly, peripheral OT affected all subdivisions of the olfactory bulb, in addition to 
the cerebellum and several brainstem areas relevant to the autonomic nervous system, 
including the solitary tract nucleus. The results from this imaging study do not support a 
direct central action of peripheral OT on the brain. Instead, the patterns of brain activity 
suggest that peripheral OT may interact at the level of the olfactory bulb and through 
sensory afferents from the autonomic nervous system to influence brain activity.
Keywords: oxytocin, cerebellum and emotion, olfaction and emotion, nucleus of the solitary tract, functional 
magnetic resonance imaging
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introduction
Oxytocin (OT) and OT-like peptides are evolutionarily conserved 
molecules found in all vertebrates [for review, see Gimpl and 
Fahrenholz (2001)]. Made in neurons localized to the paraven-
tricular, supraoptic nuclei and accessory nuclei of the hypothala-
mus, OT can be released into the systemic circulation through 
axons terminating in the neurohypophysis of the pituitary gland. 
As a classical neurohormone, OT functions in childbirth to 
enhance uterine contractions and in breast feeding to promote 
milk letdown. OT neurons in the hypothalamus also make effer-
ent connections to multiple areas of the brain, e.g., olfactory bulbs, 
basal ganglia, thalamus, and amygdala. As a neurotransmitter, 
OT functions in a variety of species-specific social behaviors 
associated with sexual behavior, social recognition, pair bonding, 
and maternal care [see reviews Pedersen (1997), Insel and Young 
(2001), Carter and Keverne (2002), Numan and Insel (2003), and 
Veenema and Neumann (2008)]. Collectively, as a chemical sign-
aling system, the OT released peripherally into the blood stream 
and that released centrally in the brain can act independently of 
one another or in concert (Landgraf and Neumann, 2004).
As a neurohormone, circulating in the blood stream, there 
are no compelling data to support the notion that physiological 
levels of OT can re-enter the brain to affect behavior. Nonetheless, 
several studies in rodents report that peripheral administration of 
OT reduces anxiety-like behavior (de Wied et al., 1987; Uvnas-
Moberg et  al., 1994; McCarthy et  al., 1996; Ring et  al., 2006; 
Klenerova et  al., 2009; Ayers et  al., 2011; Bowen et  al., 2011), 
promotes analgesia (Kang and Park, 2000), alters circadian feed-
ing patterns (Zhang and Cai, 2011), increases sexual receptivity 
in rodents (Arletti and Bertolini, 1985; Moody et al., 1994), and 
promotes prosocial behavior (Ramos et  al., 2013; Suraev et  al., 
2014; Calcagnoli et  al., 2015; Holley et  al., 2015). Interestingly, 
OT given centrally, either as a site-specific microinjection or 
intracerebroventricularly (ICV), has similar anxiolytic (Slattery 
and Neumann, 2010; Windle et al., 1997; Bale et al., 2001; Ring 
et al., 2006), analgesic (Lundeberg et al., 1994), circadian (Zhang 
and Cai, 2011) behavioral (Arletti and Bertolini, 1985; Caldwell 
et al., 1986), sexual (Witt et al., 1992), and prosocial (Williams 
et al., 1992; Lukas et al., 2011) effects. However, the mechanisms 
through which peripherally administered OT can affect behavior 
remain to be specified.
This question takes on greater importance considering the 
use of OT in the clinic. The high-profile publication of Kosfeld 
and coworkers showing that intranasal OT could enhance trust 
(Kosfeld et al., 2005), raised the possibility that this peptide given 
peripherally could be used to treat autism and other psychiatric 
conditions involving social cognition, affiliation, and bonding. 
Indeed, intranasal OT can decrease anxiety and increase vagal 
tone between parents and infants (Feldman and Eidelman, 2007), 
increase social learning, experience of attachment security, and 
social and cognitive empathy in less socially adept men (Buchheim 
et al., 2009; Bartz et al., 2010; Hurlemann et al., 2010), reduce the 
positive and negative signs of schizophrenia while improving ver-
bal learning (Feifel et al., 2010), improve social recognition, social 
behavior, and affect in patients with autism spectrum disorders 
(Andari et al., 2010; Guastella et al., 2010), reduce sensitivity to 
social threat (Bertsch et al., 2013; Puglia et al., 2015), attenuate 
the fear response (Puglia et al., 2015), and increase extinction to 
conditioned fear (Eckstein et al., 2014). However, similar to the 
rodent studies, there is no evidence to date that intranasal OT 
enters the brain in levels sufficient to directly engage OT recep-
tors or affect behavior. Thus, the mechanism of behavioral and 
emotional action remains unknown.
The purpose of the present study was to compare the pattern 
of brain activation measured in awake rats by blood oxygen level 
dependent (BOLD) imaging after exposure to OT given ICV or 
by intraperitoneal (IP) injection. If peripheral OT is able to access 
OT-sensitive neural circuits in the brain to affect behavior, we 
predicted that ICV and IP OT would activate many of the same 
brain areas, especially those containing high levels of OT recep-
tors. We also predicted that peripheral OT would be associated 
with a dose-dependent change in brain activity or behavior either 
by direct activation of central OT receptors or indirectly through 
a pharmacological ligand/receptor interaction on a peripheral 
OT signal transduction pathway.
Materials and Methods
animals
Adult, male Sprague Dawley rats were purchased from Charles 
River Laboratories (Wilmington, MA, USA). Animals were 
housed in Plexiglas cages (two per cage) and maintained in ambi-
ent temperature (22–24°C) on a 12:12 light:dark cycle (lights on at 
09:00 a.m.). Food and water were provided ad libitum. All animals 
were acquired and cared for in accordance with the guidelines 
published in the NIH Guide for the Care and Use of Laboratory 
Animals. All methods and procedures described below were pre-
approved by the Northeastern University Institutional Animal 
Care and Use Committee.
Oxytocin Preparation and administration
Oxytocin was purchased from Sigma Chemical (St Louis, MO, 
USA) and dissolved in 0.9% NaCl for IP injections or artificial 
cerebrospinal fluid for ICV injections. For the IP injections, rats 
were randomly assigned to one of four groups corresponding to 
saline vehicle, 0.1, 0.5, or 2.5 mg/kg OT. To deliver drug remotely 
during the imaging session, a poly-ethylene tube (PE-20), 
approximately 30 cm in length, was positioned in the peritoneal 
cavity. The range of doses of OT taken from the literature (Kang 
and Park, 2000; Ring et al., 2006) results in peripheral levels of 
peptides believed to be high enough to pass the blood–brain bar-
rier and engage the brain OT receptor.
Intracerebroventricular injections were administered 
through a guide cannula placed in a small aperture on the skull. 
While under isoflurane anesthesia, rats were implanted with a 
26-gage cannula of poly-ethylene tubing placed into the lateral 
cerebroventricle (2.5 mm lateral to the bregma and 5 mm below 
the dura). OT (1 μg) was given in a volume of 5 μl of artificial 
CSF during the scanning session. The rationale and methods for 
ICV injections in rats during imaging have been described in 
detail previously (Febo et al., 2004) and the dose of OT chosen 
was shown to increase BOLD signal in the OT neural circuit in 
lactating rats (Febo et al., 2005).
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acclimation for awake imaging
To reduce the stress associated with head restraint, rats were 
acclimated to the restraining system (head holder and body tube) 
1 week prior to their actual imaging session. The design of the 
restraining system included a padded head support obviating 
the need for ear bars helping to reduce animal discomfort while 
minimizing motion artifact. These acclimation sessions were run 
each day for four to five consecutive days. Rats were briefly anes-
thetized with 2–3% isoflurane while being secured into the head 
holder. The forepaws were secured with surgical tape. When fully 
conscious, the imaging system was placed into a black opaque 
box “mock scanner” for 30  min with a tape-recording of the 
MRI pulse sequence to simulate the bore of the magnet and the 
imaging protocol. A significant decline in respiration, heart rate, 
motor movements, and plasma corticosterone has been measured 
when the first and last acclimation periods are compared (King 
et al., 2005). The reduction in autonomic and somatic measures 
of arousal and stress improves the signal resolution and quality 
of the images.
image acquisition
Animals were scanned at 300 MHz using a quadrature transmit/
receive volume coil built into the rat head holder and restraining 
system for awake animal imaging (Animal Imaging Research, 
Holden, MA, USA). A video of the rat preparation for imaging 
is available at www.youtube.com/watch?v=JQX1wgOV3K4. 
The design of the coil provided complete coverage of the brain 
from olfactory bulbs to brain stem with excellent B1 field homo-
geneity. Experiments were conducted using a Bruker Biospec 
7.0  T/20-cm USR horizontal magnet (Bruker, Billerica, MA, 
USA) and a 20-G/cm magnetic field gradient insert (ID = 12 cm) 
capable of a 120-μs rise time. At the beginning of each imaging 
session, a high-resolution anatomical data set was collected using 
the RARE pulse sequence [22 slice; 1.0 mm; field of view (FOV) 
3.0 cm; matrix size 256 × 256; repetition time (TR) 2.5 s; echo 
time (TE) 12  ms; NEX 2; 3  min acquisition time]. Functional 
images were acquired using a multi-slice half-Fourier acquisition 
single-shot turbo spin echo (HASTE) pulse sequence. Bruker 
Paravision automatically finds the basic frequency, shims, power 
requirements for 90° and 180° pulses and sets the receiver gain. 
A single scanning session acquired 22 slices, 1.0 mm thick, every 
6.0 s (TR), using an effective TE of 48 ms, FOV 3.0 cm, matrix 
size 96 ×  96, NEX 1, and repeated 250 times for a total scan-
ning time of 25 min. The in-plane pixel resolution was 312 μm2. 
Each scanning session was continuous, starting with 50 baseline 
image acquisitions, followed by vehicle or OT administration 
and continuing for another 200 image acquisitions. It should be 
noted that the ICV experiments did not acquire images from the 
olfactory bulb as was the case of the IP injections. This difference 
was due to a slice acquisition of 20 for ICV and 22 for IP. It should 
also be emphasized that high neuroanatomical fidelity and spatial 
resolution are critical in identifying distributed neural circuits 
in any animal imaging study. Many brain areas in a segmented 
rat atlas have in-plane boundaries of less than 400 μm2 and may 
extend for over 1000 μm in the rostral/caudal plane. With the 
development of a segmented, annotated 3D MRI atlas for rats 
(Ekam Solutions, Boston, MA, USA), it is now possible to localize 
functional imaging data to precise 3D “volumes of interest” in 
clearly delineate brain areas. Therefore, it is critical that the func-
tional images are a very accurate reconstruction of the original 
brain neuroanatomy as shown in Figure 1.
The HASTE sequence, a spin-echo multislice pulse sequence 
used in these studies, corrects for field inhomogeneity, suscepti-
bility artifact, chemical shift, and other imaging distortions and 
FigUre 1 | neuroanatomical fidelity. Shown are representative examples 
of brain images collected during a single imaging session using a multi-slice 
spin echo, RARE (rapid acquisition with relaxation enhancement) pulse 
sequence. The column on the right shows axial sections collected during the 
anatomical scan taken at the beginning of each imaging session using a data 
matrix of 256 × 256, 22 slices in a field of view of 3.0 cm. The column on the 
left shows the same images but collected for functional analysis using 
HASTE, a RARE pulse sequence modified for faster acquisition time. These 
images were acquired using the same field of view and slice anatomy but a 
larger data matrix of 96 × 96. The images in the middle column have been 
smoothed during pre-processing. Note the anatomical fidelity between the 
functional images and their original anatomical image. The absence of any 
distortion is necessary when registering the data to atlas to resolve 171 
segmented brain areas.
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does not require any additional shimming as would be the case 
for gradient-echo pulse sequences which are commonly used in 
BOLD imaging studies. The major disadvantage to the HASTE 
sequence as compared to gradient echo is loss of signal contrast. 
The problem of sensitivity can be addressed with higher field 
strengths as used here (7  T) where the BOLD signal becomes 
a function of dynamic dephasing from diffusion of water at the 
level of the capillaries (Duong et al., 2003; Norris, 2006). Using 
multislice fast spin-echo sequences, the signal contrast with 
BOLD imaging is a function of T2 and not T2* at high field 
strengths. The extravascular signal surrounding capillary beds 
and small vessels is more reflective of the metabolic changes in 
brain parenchyma than signal from large draining veins helping 
to improve the localization of the signal changes (Yacoub et al., 
2007). The BOLD signal is linear and reproducible at stimulus 
intervals of 1 s (Zhang et al., 2009). Positive BOLD signal repre-
sents an increase in oxygenated blood content when compared 
to baseline, and negative BOLD a decrease. Sustained negative 
BOLD may be attributed to a decrease in cerebral blood flow due 
to neural inhibition or redistribution of blood flow into neighbor-
ing regions of high activity (“vascular steal”) (Kim and Ogawa, 
2012).
Data analysis
Data were co-registered to a mean functional image using SPM8’s 
co-registrational code with the following parameters: quality, 0.97; 
smoothing, 0.35 mm; and separation, 0.5 mm. Gaussian smooth-
ing was performed with a FWHM of 0.8 mm. Preprocessed func-
tional files were then exported to Medical Image Visualization 
and Analysis (MIVA) for registration and segmentation. Images 
were aligned and registered to a 3D rat brain atlas, which is seg-
mented and labeled with 171 discrete anatomical regions. Note 
the reduced slice acquisition in the ICV experiment eliminated 
the olfactory bulb and reduced the number of anatomical regions 
of the rat atlas to 163. The alignment process was facilitated by 
an interactive graphic user interface. The registration process 
involved translation, rotation, and scaling independently and in 
all three dimensions. Matrices that transformed each subject’s 
anatomy were used to embed each slice within the atlas. All pixel 
locations of anatomy that were transformed were tagged with 
regions of interest in the atlas. This combination created a fully 
segmented representation of each subject within the atlas. The 
inverse transformation matrix [Ti]-1 for each subject (i) was also 
calculated.
For voxel-based analysis, the percent change in BOLD signal 
for each independent voxel was averaged for all subjects with a 
baseline threshold of 2% BOLD change to account for normal 
fluctuation of BOLD signal in the rat brain under the awake 
condition (Brevard et al., 2003). A composite image of the whole 
brain representing the average of all subjects was constructed 
for each group for ROI analyses, allowing us to look at each ROI 
separately to determine the BOLD change and the number of 
activated voxels in each ROI. The t-test statistics used a 95% confi-
dence level, two-tailed distributions, and heteroscedastic variance 
assumptions. As a result of the multiple t-test analyses performed, 
a false-positive detection controlling mechanism was introduced 
(Genovese et al., 2002). This subsequent filter guaranteed that, on 
average, the false-positive detection rate was below our cutoff of 
0.05. Statistical t-tests were performed on each voxel (ca. 15,000 in 
number) of each subject within their original coordinate system. 
The average signal intensity in each voxel of the first 5  min of 
baseline (1–50) was compared to 5–15 min (acquisitions 51–150) 
and 15–25  min (acquisitions 151–250) post OT. Volume of 
activation was compared across experimental groups using the 
non-parametric Kruskal–Wallis test statistic. The brain areas were 
ranked in order of their significance. Brain areas were considered 
statistically different between experimental groups when com-
parison produced P-values less than or equal to our cutoff of 0.05. 
Post hoc analyses were performed with a Wilcoxon rank-sum test.
Oxytocin receptor Binding
Because of the pattern of BOLD activation seen in the olfactory 
bulb (see Results), OT receptor autoradiography was performed 
on the olfactory bulb of male Sprague Dawley rats. Rats were 
anesthetized under CO2 and decapitated. Brains were removed 
and quickly frozen in methylbutane on dry ice, and stored at 
−80°C. Olfactory bulbs were cut into 16-μm axial sections on a 
cryostat and mounted on slides. The receptor autoradiography 
procedure was performed according to Lukas et al. (2010) using 
[125I]-Ornithine Vasotocin Analog (d(CH2)5[Tyr(Me)2,Thr4,Or
n8,[125I]Tyr9-NH2]-OVTA; Perkin Elmer, USA) as tracer for the 
OTR. Briefly, the slides were thawed and dried at room tem-
perature. Slides were then fixed in 0.1% paraformaldehyde and 
washed two times in Tris buffer (pH 7.4). The slides were then 
exposed to tracer buffer (Tris + 10 mM MgCl2, 0.1% BSA, and 
tracer) for 60 min, and then washed four times in Tris + MgCl2. 
The slides were then dipped in distilled water, dried, and exposed 
to film (Kodak) for 7 days.
results
central versus Peripheral Oxytocin
The 3D color model at the top of Figure 2 depicts the location 
of 14 brain areas in the rat reported to have a high density of OT 
receptor binding (De Kloet et al., 1985; van Leeuwen et al., 1985; 
Freund-Mercier et al., 1987; Tribollet et al., 1988; Dumais et al., 
2013). These areas have been coalesced into a single volume (yel-
low) as shown in the lower 3D images for ICV and IP administra-
tions of vehicle and OT. Areas in red are the composite average 
of the significant increase in volumes of activation (number of 
voxels in a ROI) for positive BOLD from all rats for each condi-
tion. The median (Med) number of positive and negative voxels 
activated for both vehicle and OT within 10 min of ICV and IP 
(2.5 mg/kg) injection are shown in the tables below. These brain 
areas are ranked in order of their significance. These data from 
all brain areas are presented in the 3D activation maps. Of the 
14 areas having a high density of OT binding sites, eight were 
significantly activated by ICV OT as shown in the table below 
highlighted in red. Only one area, the ventral subiculum, was 
activated by IP OT within the first 10 min of injection. There was 
no significant change in negative BOLD for ICV OT; while IP 
OT reduced activity in the anterior olfactory nucleus and ventral 
medial hypothalamus shown highlighted in blue. By 20  min 
post ICV OT injection, there were neither positive nor negative 
FigUre 2 | neural circuitry of high-density OT receptor binding sites. The 3D color model at the top depicts the location of 14 brain areas in the rat reported 
to have a high density of OT receptor binding (De Kloet et al., 1985; van Leeuwen et al., 1985; Freund-Mercier et al., 1987; Tribollet et al., 1988). These areas have 
been coalesced into a single volume (yellow) as shown in the lower 3D images for ICV and IP administrations. Areas in red are the localization of the activated voxels 
comprising the composite average from the rats in each experimental group. Once fully registered and segmented, the statistical responses for each animal are 
averaged on a voxel-by-voxel bases. Those averaged voxels that are significantly different from baseline for positive BOLD are shown in their appropriate spatial 
location. Below are tables of these regions of interest for negative and positive BOLD at 10 and 20 min post ICV and IP OT. All areas are ranked in order of their 
significance. The brain areas highlighted in red and blue show significant changes in volumes of activation.
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FigUre 4 | The 3D color model at the top depicts the location of the 
brains that comprise the primary olfactory system in the rat. These 
areas have been coalesced into a single volume (yellow) as shown in the 
lower 3D images for intraperitoneal OT (n = 12) and vehicle (n = 12). Areas in 
red (positive BOLD) and blue (negative BOLD) are the localization of the 
significantly changed voxels comprising the composite average from the rats 
in each experimental group.
FigUre 3 | Onset of BOlD signal change: intracerebroventricular 
versus intraperitoneal oxytocin. Shown are the time-course plots for the 
change in BOLD signal in the superior colliculus following injection (arrow) of 
OT into the lateral cerebroventricle (gray, n = 8) or peritoneal cavity (black 
n = 11).
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changes in BOLD signal that reached significance. At the same 
time period, IP OT caused a significant increase in BOLD signal 
in the accumbens shell and decrease in signal in the olfactory 
tubercles.
The volume of activation for all brain areas ranked in order 
of their significance for ICV OT versus vehicle at 10 and 20 min 
post injection can be found in Tables S1 and S2 in Supplementary 
Material, respectively. Similarly, Tables S3 and S4 (Supplementary 
Material) show the volume of activation for all 171 brain areas for 
IP OT, 0.1 (n = 9), 0.5 (n = 13), and 2.5 (n = 12) mg/kg versus 
vehicle for 10 and 20 min post injection, respectively.
It should be noted that there is no clear dose-dependent change 
in the volume of activation for positive or negative BOLD at either 
time period for IP OT. A U-shaped pattern where OT doses of 
0.1 and 2.5 are higher than the intermediate dose of 0.5 appears 
over most of the brain regions that show positive activation. 
Time-course plots showing the change in BOLD signal intensity 
in the superior colliculus for both ICV and IP administration 
of OT are presented in Figure  3. The superior colliculus was 
chosen because it showed robust activation with ICV (see Table 
S1 in Supplementary Material) and IP injections (see Table S3 
in Supplementary Material). The change in BOLD signal occurs 
earlier with ICV injection by approximately 1 min as compared to 
IP (route × time: F11,187 = 37.64, P < 0.0001). The response peaks in 
around 2 min for ICV injection and about 4 min for IP injection.
activation of the Primary Olfactory system
By 20 min post IP OT administration, the number of activated brain 
areas is considerably reduced as compared to the first 10 min as 
shown in Table S3 in Supplementary Material. Several of the areas 
that remain significantly activated are part of the primary olfac-
tory system (POS), e.g., external plexiform layer, glomerular layer, 
cortical amygdala, and rostral piriform cortex. Figure 4 shows 3D 
BOLD activation maps for vehicle and OT in the POS. The images 
at the top are color-coded and labeled for each 3D volume. As 
in Figure  2, these different volumes are coalesced into a single 
FigUre 5 | intraperitoneal oxytocin and the olfactory bulb. The 3D images in the top left corner are magnifications of the olfactory bulbs shown in Figure 4. 
Below on the left are 2D activation maps from the rat brain atlas showing the precise location of the significantly altered positive (red) and negative (blue) voxels 
following IP OT (2.5 mg). The figures on the right show the localization of the voxels on the original neuroanatomical images. The vertical color strip indicates the 
percent change in BOLD signal. The lines (A, B, C) through the 3D top images show the approximate position of the axial 2D images below. The middle figure in the 
bottom panel shows the positive BOLD activation pattern on the original bulb neuroanatomy while the left figure shows the specific layers segmented and annotated 
as they appear in the rat atlas. The figure to right shows an autoradiogram of approximately the same section depicting OT binding in the granular layer (dark 
contrast). The tables show the median number of positive and negative for vehicle, 0.1, 0.5, and 2.5 IP OT at 10 and 20 min post IP injection. For the 0.1 mg dose 
positive BOLD, 10 and 20 min: *P < 0.05 **P < 0.01 compared to Veh; ^P < 0.05 compared to 2.5 mg; §P < 0.05 compared to 2.5 mg. For the 0.5 mg dose 
positive BOLD 10 and 20 min: * < 0.05 **P < 0.01 compared to Veh; βP < 0.05 compared to 2.5 mg. For the 2.5 mg dose positive BOLD, 10 and 20 min: 
**P < 0.01 compared to Veh. For the 0.1 mg dose negative BOLD, 20 min: **P < 0.01 compared to Veh; §P < 0.05 compared to 2.5 mg. For the 0.5 mg dose 
negative BOLD 10 and 20 min: * < 0.05 **P < 0.01 compared to Veh. For the 2.5 mg dose negative BOLD, 10 and 20 min: *P < 0.05 **P < 0.01 compared to Veh; 
§P < 0.05, +P < 0.01 compared to 0.1 mg.
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volume (yellow) showing the location in red of the average of the 
significant increase in volumes of activation (number of voxels in 
a ROI) for positive BOLD from all rats for each condition. These 
data are from the 2.5 mg/kg dose of OT acquired in the first 10 min 
post injection (see Tables S3 and S4 in Supplementary Material). 
Note the high activation of both positive and negative BOLD in 
the olfactory bulb (granular cell layer, glomerular layer, external 
plexiform layer) with OT treatment as compared to vehicle.
The changes in positive and negative BOLD in the different 
areas of the olfactory bulb are better viewed in the 2D activation 
maps shown in Figure 5. At top is an enlargement of the olfactory 
bulbs depicting the 3D activation maps for positive and negative 
BOLD. The volumes of activation for each area of the bulb and the 
other areas of the POS for both the 10 and 20 min time periods are 
shown in the tables to the right. The data used to generate the 3D 
and 2D activation maps were taken from the vehicle and 2.5 mg/kg 
dose of OT collected during the 10-min time period. The precise 
location of the positive and negative voxels is shown registered 
to the MRI rat atlas and the original anatomy. These composites 
are the average number of voxels showing a significant increase 
above baseline for vehicle (n = 12) and 2.5 mg OT (n = 12). The 
approximate locations of the 2D axial sections relative to the 3D 
activation maps are indicated by the lines A, B, and C. It is clear 
from the position of positive and negative BOLD voxels that they 
do not overlap. Time-course plots showing the change in positive 
and negative BOLD signals in the glomerular and granular layers 
are presented in Figure 6. The insert shows a higher magnification 
of the first 3 min post IP injection of OT. Within the first minute, 
there is a significant decrease in negative BOLD over baseline for 
both glomerular layer (t11 = 4.27, P = 0.001) and granular layer 
(t11 = 4.14, P = 0.002). However, it is not until 3 min post injection 
that the positive BOLD significantly exceed baseline (glomerular: 
t10 = 3.70, P = 0.004; granular: t10 = 3.09, P = 0.01) showing the 
negative BOLD activation pattern precedes the positive BOLD in 
the olfactory bulb (negative versus positive × time: F24,1056 = 42.06, 
P < 0.0001). As noted above, Tables S3 and S4 in Supplementary 
FigUre 6 | Time-course plots for positive and negative BOlD in the olfactory bulb. Shown are the changes in positive (red) and negative (blue) BOLD 
signals over time in the glomerular and granular layers of the olfactory bulb following intraperitoneal injection of OT. The insert is a magnified cut-out of the 3 min 
following injection. The thick lines show trend lines as an average of eight acquisitions. Vertical bars denote SEM.
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Material show a high level of significant activity in many brain 
areas within the first 10 min of OT administration that is greatly 
reduced by 20 min post peptide. The major exception to this trend 
at 10 and 20 min post OT is the POS, particularly the olfactory 
bulbs. As shown in the tables attached to Figure 5, all doses of 
OT show significant changes in negative and positive BOLD from 
vehicle (*<0.05, **<0.01). Given the significant increase in BOLD 
activation in the olfactory bulb after IP OT, we performed recep-
tor autoradiography to determine the presence of OT receptor 
binding in olfactory bulb layers. OT receptor binding was highest 
in the granular cell layer of the olfactory bulb. By contrast, there 
was faint OT receptor binding in the external plexiform layer and 
glomerular layer of the olfactory bulb. The distribution of OT 
receptor binding in the olfactory bulb is illustrated in Figure 5.
activation of Brainstem and cerebellum
How does one account for the many brain areas, particularly 
those localized to the brainstem, that are activated by IP OT? 
One hypothesis focuses on the notion that IP OT can stimulate 
OT receptors found on many peripheral organs, e.g., heart, blood 
vessels, urogenital system, etc. (Gimpl and Fahrenholz, 2001) 
that are innervated by the autonomic nervous system. Hence, 
Figure  7 shows a composite of several brain areas involved in 
processing viscero-sensory information from the autonomic 
nervous system. Many of these areas (gigantocellularis, nucleus 
of solitary tract, and parabrachial, pedunculotegmentum) have 
direct connections with viscero-sensory neurons in the spinal 
cord (Cechetto et al., 1985; Menetrey and Basbaum, 1987; Bernard 
and Besson, 1990; Menetrey and De Pommery, 1991; Krutki et al., 
1999). The nucleus of the solitary tract (NST), trigeminal, and 
vestibular areas receive sensory information from the cranial 
nerves (Torvik, 1956; Caous et al., 2012). Included in Figure 7 are 
areas of the cerebellum that also receive viscero-sensory innerva-
tion from spinal cord and cranial nerves (Newman and Paul, 
1969; Rubia, 1970; Nisimaru and Katayama, 1995; Krutki et al., 
1999). As in Figures  2 and 4, the images are color-coded and 
labeled for each 3D volumes and coalesced into a single volume 
(yellow) showing the location in red of the significant increase 
in volumes of activation for positive BOLD from all rats for each 
condition. These data are from the 2.5 mg dose of OT acquired 
FigUre 7 | hindbrain areas activated by intraperitoneal oxytocin. The 3D color model at the top left depicts the location of brain areas associated with 
activation of sensory afferents coming from the autonomic nervous system and synapses at the level of the brainstem and cerebellum. These areas have been 
coalesced into a single volume (yellow) as shown in the lower 3D images for IP vehicle (n = 12) and OT (n = 12). Areas in red are the localization of the activated 
voxels comprising the composite average from the rats in each experimental group following IP OT (2.5 mg). To the immediate right are 2D activation maps from the 
rat brain atlas showing the precise location of the significantly activated positive (red) voxels. The images to the far right show the localization of the voxels on the 
original neuroanatomical images.
September 2015 | Volume 9 | Article 2459
Ferris et al. Central versus peripheral oxytocin
Frontiers in Behavioral Neuroscience | www.frontiersin.org
in the first 10 min post injection (see Table S3 in Supplementary 
Material). The precise location of the positive voxels is shown in 
the columns to the right registered to the 2D axial section from 
the MRI rat atlas and the original anatomy. These composites are 
the average number of voxels showing a significant increase above 
baseline for vehicle (n = 12) and 2.5 mg/kg OT (n = 12).
Table  1 shows these brainstem and cerebellar areas with 
viscero-sensory inputs ranked in order of their significance 
for positive and negative BOLD at time periods 10 and 20 min 
post IP OT administration. Note the absence of any significant 
negative BOLD for either time period. The significant difference 
in positive BOLD were limited only to the first 10 min period 
post OT. Also note that the significant increase in the volume 
of activation was primarily due to the 2.5 mg/kg dose of OT as 
compared to vehicle (*<0.05, **<0.01). The 0.1 mg/kg dose also 
showed a significant increase over vehicle for trigeminal areas, 
NST, reticular, and vestibular areas.
Discussion
central versus Peripheral Oxytocin
There are over 80 papers in humans studying the effects 
of  intranasal OT on brain activity using functional MRI 
(http://www.ncbi.nlm.nih.gov/pubmed). Due to ethical consid-
erations, there are no experiments in human subjects giving OT 
directly into the brain so it is not possible to compare imaging 
data from these two different routes of administration as we have 
done so here. In a previous study, we administered OT ICV to 
lactating female rats and found activation of many of the brain 
areas constituting the OT neural circuit involved in maternal 
behavior (Febo et al., 2005). Here, we provide the first data in 
animals looking at the effects of peripheral OT on brain activity 
using BOLD imaging. In these studies, we compared data from 
IP OT to those obtained from ICV OT. Both routes of admin-
istration used doses of OT reported to have robust effects on 
behavior. The doses for IP OT (0.1–2.5 mg/kg) were deliberately 
chosen from the high end of the spectrum to favor brain pen-
etrance for behavioral effects (Newman and Paul, 1967; Kang 
and Park, 2000; Ring et  al., 2006). If we assume that 0.002% 
(Mens et al., 1983) to 0.5% (Ermisch et al., 1985) of peripheral 
OT reaches the brain within 10  min after administration as 
reported, then our range of doses should be comparable to, or 
in excess of, our ICV dose of 1.0 μg.
In both routes of administration, there were significant 
changes in BOLD signal intensity within the first 10  min after 
OT injection. It has been argued in the animal literature that 
TaBle 1 | activation in brainstem and cerebellum following intraperitoneal oxytocin.
Positive BOlD negative BOlD
region of interest (rOi) Veh 0.1 0.5 2.5 region of interest (rOi) Veh 0.1 0.5 2.5
Med Med Med Med P-value Med Med Med Med P-value
Volume activation 10 min post intraperitoneal oxytocin
Superior colliculus 8 23 0 91**§ 0.003 Reticular area midbrain 0 0 3 9 0.117
Fourth cerebellar lobule 0 0 0 43**β§ 0.003 Fifth cerebellar lobule 1 28 15 0 0.131
Anterior pretectal area 0 0 0 9**β§ 0.004 Central gray 0 0 9 0 0.171
Fifth cerebellar lobule 3 4 0 113**β§ 0.005 Fourth cerebellar lobule 0 4 0 0 0.208
Vestibular area 0 5* 0 22**§ 0.006 Vestibular area 0 0 6 1 0.274
Reticular area midbrain 1 6^ 0 10*§ 0.01 Root of trigeminal nerve 0 0 12 9 0.29
Third cerebellar lobule 0 0 0 17§ 0.011 Gigantocellular reticular pons 0 0 1 9 0.319
Root of trigeminal nerve 0 20**^ 3 11*x 0.017 Eighth cerebellar lobule 0 0 0 0 0.365
Solitary tract nucleus 0 4* 0 5*x 0.023 Principal sensory trigeminal 0 0 2 5 0.378
Second cerebellar lobule 0 0 0 12*x 0.036 Parabrachial area 0 0 0 0 0.487
Principal sensory trigeminal 0 24* 4 12* 0.044 First cerebellar lobule 0 0 0 0 0.523
Parabrachial area 0 0 0 0 0.112 Superior colliculus 0 12 5 1 0.562
Pedunculopontine tegmentum 0 0 0 0 0.162 Third cerebellar lobule 0 2 4 1 0.586
Eighth cerebellar lobule 0 0 0 5 0.287 Second cerebellar lobule 0 1 1 0 0.654
Central gray 0 0 0 0 0.295 Solitary tract nucleus 0 0 0 0 0.692
First cerebellar lobule 0 0 0 0 0.554 Pedunculopontine tegmentum 0 0 0 0 0.817
Gigantocellular reticular pons 0 4 0 3 0.573 Anterior pretectal area 0 0 0 0 0.843
Motor trigeminal area 0 0 0 0 0.733 Motor trigeminal area 0 0 0 0 0.987
Volume activation 20 min post intraperitoneal oxytocin
Reticular area midbrain 11 33 14 18 0.055 Third cerebellar lobule 7 18 0 6 0.08
Fourth cerebellar lobule 0 1 9 43 0.08 First cerebellar lobule 0 3 0 0 0.089
Solitary tract nucleus 0 5 2 9 0.081 Central gray 0 8 6 0 0.1
Eighth cerebellar lobule 0 0 0 13 0.094 Fourth cerebellar lobule 6 20 0 5 0.129
Fifth cerebellar lobule 16 17 32 73 0.114 Gigantocellular reticular pons 12 5 5 29 0.178
Motor trigeminal area 0 0 0 0 0.115 Reticular area midbrain 2 7 13 18 0.219
Parabrachial area 0 2 1 4 0.121 Fifth cerebellar lobule 42 65 3 24 0.293
Superior colliculus 50 69 59 82 0.134 Second cerebellar lobule 2 5 1 4 0.37
Root of trigeminal nerve 10 33 19 21 0.141 Root of trigeminal nerve 8 12 23 24 0.567
Vestibular area 3 13 16 22 0.175 Eighth cerebellar lobule 0 0 0 0 0.569
Principal sensory trigeminal 2 18 22 27 0.179 Motor trigeminal area 0 0 0 0 0.608
Anterior pretectal area 1 5 5 7 0.207 Vestibular area 4 17 3 2 0.626
Third cerebellar lobule 4 5 9 17 0.218 Principal sensory trigeminal 11 7 19 18 0.692
Pedunculopontine tegmentum 0 0 0 0 0.331 Parabrachial area 0 0 2 0 0.717
Second cerebellar lobule 8 13 8 26 0.338 Pedunculopontine tegmentum 0 0 0 0 0.744
Gigantocellular reticular pons 1 11 32 9 0.585 Solitary tract nucleus 0 0 0 2 0.775
Central gray 3 0 0 2 0.839 Superior colliculus 16 41 23 28 0.87
First cerebellar lobule 0 0 0 0 0.979 Anterior pretectal area 0 0 0 0 0.986
Shown are the median (Med) number of positive and negative voxels in brainstem and cerebellar areas affected 10 and 20 min following IP injections of vehicle (Veh n = 12), 0.1 (n = 9), 0.5 (n = 13), and 2.5 (n = 12) mg OT. 
The regions of interest are ranked in order of their significance. Probability values are presented on the far right column. The red highlights the significantly activated areas. The voxel numbers for each condition were analyzed using 
a Newman–Keuls multiple comparisons test statistic. For the 0.1 mg dose positive BOLD at 10: *P < 0.05 **P < 0.01 compared to Veh; ^P < 0.05 compared to 0.5 mg. For the 2.5 mg dose positive BOLD at 10 min: *P < 0.05 
**P < 0.01 compared to Veh, §P < 0.01 compared to 0.5 mg; βP < 0.01 compared 0.1 mg.
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intranasal (Neumann et al., 2013) and IP (Ring et al., 2006) OT 
administration can directly affect OT neurotransmission in the 
brain. If so, we would expect that the ICV and IP injections of OT 
should show some similarity in brain activity. However, this was 
not the case. We used the density of OT receptors to identify the 
key nodes in a putative OT neural circuit as shown in Figure 2. 
The 14 brain areas shown in Figure 2 are not unique to rats but 
common to a variety of rodent species (Gimpl and Fahrenholz, 
2001; Beery et al., 2008; Rosen et al., 2008; Campbell et al., 2009). 
While ICV OT significantly activated eight of these brain areas, 
IP OT activated only one. This would suggest that peripheral 
OT does not get into the brain in high enough concentration to 
effectively engage the OT receptor as compared to direct ICV OT 
within the first 20 min.
The question whether circulating OT from any peripheral 
route of administration can effectively cross the blood–brain bar-
rier has been a topic of debate for many years (Churchland and 
Winkielman, 2012). While several studies have claimed elevations 
in CSF levels of OT following intranasal OT administration (Chang 
et al., 2012; Neumann et al., 2013; Striepens et al., 2013; Modi et al., 
2014), it is not possible to distinguish OT released from endogenous 
stores, from OT given peripherally. There are several reports that 
intranasal OT is accompanied by an increase in plasma levels of OT 
(Landgraf, 1985; Cavdar et al., 2001; Gossen et al., 2012; Striepens 
et al., 2013). This coupled with the fact that OT given intravenously 
has many of the same behavioral effects reported for intranasal OT 
(Hollander et al., 2003, 2007; Bartz and Hollander, 2008) suggests 
that the intranasal and intravenous routes of administration in 
humans are acting on a peripheral transduction pathways to affect 
brain activity. This issue should be clearly resolved using quantita-
tive chemical methods providing indisputable evidence that intra-
nasal OT, or any other peripheral source of OT, achieves adequate 
levels in the brain to stimulate the OT receptor. These issues were 
thoroughly addressed in a study by Ludwig and colleagues compar-
ing the neurobiological effects of ICV and intranasal vasopressin 
and OT in rats (Ludwig et al., 2013). The methodological concerns 
surrounding intranasal peptide administration have recently been 
reviewed by Leng and Ludwig (2015).
activation of the Primary Olfactory system
The most compelling finding in this imaging study was the 
significant activation of the POS by IP OT. There are numerous 
studies showing that the POS, indeed the olfactory bulb itself, is a 
critical brain area in mammals for processing and remembering 
socially relevant odors for use in social recognition and learning 
[review see Sanchez-Andrade and Kendrick (2009)]. Maternal 
behavior in rats and mice (Gandelman et al., 1971; Fleming and 
Rosenblatt, 1974), maternal recognition of offspring in sheep 
(Baldwin and Shillito, 1974), and social recognition in male rats 
(Dantzer et al., 1990) require the olfactory bulbs. The memory 
preservation of social recognition of juvenile female conspecifics 
is reduced with injection of OT receptor antagonist into the olfac-
tory bulb (Larrazolo-Lopez et al., 2008) while OT infused in the 
olfactory bulbs of male rats preserves the memory of prior social 
interactions (Dluzen et  al., 1998). Indeed, the olfactory bulb 
and its downstream connections to cortical amygdala, medial 
amygdala, BNST, and medial preoptic areas are all integrated in 
social recognition and all are sensitive to OT neurotransmission. 
It remains to be explored whether peripheral OT can gain direct 
access to the olfactory bulbs through the nasal epithelium as some 
predict (Guastella et al., 2013).
Oxytocin is not synthesized in neurons in the rat olfactory 
bulb (Tobin et  al., 2010). However, there are OT fibers in the 
granular cell layer (Larrazolo-Lopez et al., 2008) that are thought 
to originate in the paraventricular nucleus of the hypothalamus 
(PVN) (Sawchenko and Swanson, 1982; Knobloch et al., 2012). 
Indeed, as shown in Figure 5, OT receptor binding is primarily 
confined to this area of the bulb. The granular cells are GABAergic 
and mingle with dendrites from mitral cells in the external 
plexiform layer. Activated granular cells inhibit mitral cell activ-
ity and output from the bulb to the anterior olfactory nucleus 
and olfactory cortex. It is thought that OT functions at the level 
of the bulb by inhibiting norepinephrine input coming into the 
granular layer (Sanchez-Andrade and Kendrick, 2009). The in-
plane spatial resolution in these functional imaging studies was 
limited to 320 μm2 making it impossible to resolve the single layer 
of mitral cells that line the border between the external plexiform 
and glomerular layers; however, it is possible to see activity in 
the larger glomerular, external plexiform, and granular layers as 
shown in Figure 5. The first area of the olfactory bulb to receive 
input from the olfactory epithelium is the glomerulus. Based 
on the time-course data in Figure 6, the appearance of negative 
BOLD in both the glomerular and granular layers precedes the 
positive BOLD by close to 1 min. The granular cell layer shows 
a high level of significant negative BOLD during the first 10 min 
post OT and continues this trend over the 20 min imaging period 
(Figure  5). The glomerular layer, receiving direct inputs from 
sensory olfactory epithelium, remains significantly activated for 
both negative and positive BOLD over the 20 min imaging period 
as does the external plexiform layer. A significant activation of 
the cortical amygdala and rostral piriform cortex only appears at 
20 min post IP OT. The sustained negative BOLD or diminished 
activity in the granular cell layer may account for the late activa-
tion of the olfactory cortex. Since norepinephrine excites granu-
lar cells which then inhibit mitral cells, OT could be decreasing 
noradrenergic transmission thereby increasing mitral cell activity 
and communication to efferent targets of the olfactory bulb.
activation of the nucleus of the solitary Tract
As noted earlier, there are OT receptors in the male and female 
reproductive system, kidney, mammary glands, heart, vascular 
smooth muscle, and thymus (Gimpl and Fahrenholz, 2001). All 
of these organs are innervated by the autonomic nervous system. 
We hypothesized that following peripheral OT receptor activa-
tion, viscero-sensory information would be conveyed back to the 
brainstem through spinal cord and cranial nerves to affect BOLD 
signal intensity in many areas in the hindbrain associated with 
autonomic function. The NST, parabrachial and gigantocellularis 
nuclei, and reticular formation, key areas in the integration of 
viscero-sensory information, have direct sensory connections 
with spinal neurons (Menetrey and De Pommery, 1991). The 
anticipated areas of activation in the hindbrain from autonomic 
sensory fibers are shown in Figure 7. We did not see significant 
changes in BOLD signal in the parabrachial and gigantocellular 
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areas with IP OT but several other areas, most importantly, the 
NST was activated. The NST is involved in the regulation of sev-
eral visceral functions, particularly cardiovascular reflexes and 
vagal control of heart rate (Higa et al., 2002; Vela et al., 2010). 
Interestingly, central OT has an important role in regulating NST 
activity. The NST is high in both OT receptors and OT fibers 
(Buijs et al., 1990; Rinaman, 1998). OT neurons from the PVN 
have direct connections to the NST and function to facilitate 
vagal afferent transmission (Peters et al., 2008). Electrical stimu-
lation of the PVN increases OT release in the NST (Landgraf and 
Neumann, 2004). Stimulation of vagal afferents increases activity 
in the PVN resulting in the release of OT in extrahypothalamic 
areas (Larrazolo-Lopez et al., 2008). The NST has extensive recip-
rocal connections with brain stem reticular activating system as 
well as the PVN (Ricardo and Koh, 1978; Herbert et al., 1990).
One intriguing hypothesis that finds support in this imag-
ing study is OT activation of brain stem areas, particularly the 
NST, that would be involved in the “social engagement system” 
as proposed by Porges (2004). It is hypothesized that dysregula-
tion of somatomotor function related to facial expression, visual 
tracking and gaze, head gestures, and auditory function can 
impact social and emotional behaviors. While higher cortical and 
subcortical areas control these somatomotor functions, afferent 
feedback from the vagus nerve to the NST affects the state of 
arousal and anxiety to impede or foster the activity of the social 
engagement system. This hypothesis has found support in several 
studies examining the physiologic state of infants with respect 
to the synchrony between mother–infant interactions (Moore 
and Calkins, 2004; Feldman, 2006; Feldman and Eidelman, 2007; 
Feldman et al., 2010). High vagal tone in infants, a measure of 
autonomic maturation and the ability to set a physiological state 
of “calmness,” assists in the establishing the mother–infant bond.
Why the cerebellum?
We were surprised to see that many areas of the cerebellum were 
significantly activated with IP OT. Traditionally, the cerebellum 
was thought of as a brain structure involved in fine motor coor-
dination; however, there are many early studies using stimulation 
and lesion techniques reporting that the cerebellum is involved 
in autonomic physiology, e.g., heart rate, blood pressure, 
respiration, piloerection (Snider and Maiti, 1976; Haines et al., 
1984; Cavdar et al., 2001) and, more recently, a role in emotion 
and cognition (Newman and Paul, 1969; Haines et  al., 1984; 
Perciavalle et al., 2013). There are reciprocal connections between 
the cerebellum and the hypothalamus, limbic cortex, amygdala, 
and hippocampus (Snider and Maiti, 1976; Heath et  al., 1978; 
Haines et al., 1984; Calcagnoli et al., 2015). The cerebellum not 
only exercises efferent control of autonomic function but is also 
directly affected by visceral afferents via the splanchnic nerve 
(Newman and Paul, 1966, 1969; Langhof et al., 1973) and vagus 
nerve (Newman and Paul, 1966; Rubia and Phelps, 1970; Okahara 
and Nisimaru, 1991; Kondo et al., 1998). The cerebellum receives 
much of its innervation from the vestibular complex, the brain 
area relaying auditory information from the ear to the cortex. In 
addition to the cerebellum, the vestibular complex also has recip-
rocal connections with the NST (Jaarsma et al., 1997; Perciavalle 
et al., 2013) and the brainstem reticular formation which might 
explain its activation with peripheral OT. It was proposed by 
Cavdar and coworkers that the brainstem, particularly the NST, 
trigeminal, and vestibular nuclei together with the cerebellum 
interact with forebrain areas particularly the hypothalamus to 
regulate autonomic function (Cavdar et al., 2001). All of these 
brainstem areas were activated by IP OT. Hence, the cerebellum 
may be coordinating the autonomic response to the interoceptive 
environment activated by IP OT.
limitations and considerations in Data 
interpretation
The stress associated with head restraint, restricted movement 
in the body tube, noise from the gradient coil, and the dura-
tion of the imaging session are all concerns when imaging 
awake animals. To address these problems, protocols have been 
developed for acclimating animals to the environment of the MR 
scanner and imaging procedure leading to a reduction in stress 
hormones levels and measures of autonomic activity regulated by 
the sympathetic nervous system [see review Ferris et al. (2011)]. 
Acclimation to the scanning session is achieved by putting sub-
jects through several simulated imaging studies as described in 
the Section “Materials and Methods.” While it can be shown that 
signs of autonomic arousal and stress are reduced with acclima-
tion, they are not eliminated entirely and that some stress is still 
likely with the imaging procedure. Thus, the OT-induced changes 
in BOLD signal intensity observed in these studies by either 
route of administration may have occurred against a backdrop of 
heightened arousal and stress over the 20 min imaging session.
There was no clear dose-dependent change in positive BOLD 
signal intensity to IP OT. The three doses of OT (0.1, 0.5, and 
2.5 mg/kg) presented as a U-shaped curve with 0.5 mg/kg having 
little effect. Ramos and colleagues measuring social behavior in 
rats used similar doses of OT (0.1, 0.25, 0.5, and 1.0 mg/kg) given 
IP and failed to show a clear dose-response as only the 0.5 mg/kg 
dose had any significant effect (Ramos et al., 2013). The low dose 
of 0.1 mg/kg and high dose of 2.5 mg/kg used in our study brack-
ets much of the behavioral literature although there are reports 
of behavioral effects with as little as 0.1–5.0 μg/kg of OT (Moody 
et al., 1994; Missig et al., 2010; Helena et al., 2011), a 1000-fold 
less than reported in most studies. OT has a very high binding 
affinity for its receptor (<0.5 nM) and the range of doses reported 
in the literature following systemic administration would easily 
engage the receptors – both central and peripheral, if the target 
could be reached. The broad range of peripheral doses used in 
behavioral studies, many of them pharmacologic as here, raises 
the possibility that OT could be interacting with other receptors. 
OT does have a moderate affinity for the arginine vasopressin 
V1a receptor (ca 100 nM) (Manning et al., 2012) and could be 
stimulating this signaling pathway to affect behavior. Evidence 
to this point comes from Ramos and colleagues showing that the 
behavioral effects they observed with OT treatment were also 
caused by vasopressin and that the effects of both peptides on 
social behavior could be blocked by a V1a receptor antagonist 
(Ramos et al., 2013). Similar results were reported for the ham-
ster (Song et al., 2014). Hence, clear dose-dependent changes in 
behavior and in this case, BOLD signal, may be confounded by 
OT interacting with V1a receptors.
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speculation
Interestingly, most of the activation, both positive and negative 
BOLD, occurred within the first 10 min post injection for both 
routes of OT administration. This raises a very interesting ques-
tion. Why and how does a peptide with such a short half-life in 
the circulation (ca 1–5 min) (Meyer et al., 1987) have behavioral 
effects that last for hours as shown in myriad studies? While 
speculative, the answer may be found in the olfactory bulb, the 
only area in our study that remained activated over the 20 min 
imaging period (see Figure  5). Exogenous OT may set into 
motion central processes that sustain continued activation of 
POS. Thus, a burst of circulating OT may prime the olfactory bulb, 
which when combined with centrifugal inputs from the brain and 
autonomic nervous system via brainstem and cerebellum sustains 
a behavioral response in the context of relevant olfactory cues.
We can speculate further on the role of the cerebellum in 
OT-mediated behavior. Release of endogenous OT coordinates a 
visceral response to the relevant environmental stimulus which 
feeds back to the cerebellum creating an unconscious visceral 
template that reflects the intensity and valance of the stimulus. 
The stimulus is screened and evaluated at the level of the olfac-
tory bulb – a function involving an interaction between OT and 
noradrenergic inputs from the locus coeruleus (Sanchez-Andrade 
and Kendrick, 2009). The coordinated emotional, cognitive, and 
behavioral response to the stimulus involves reciprocal connec-
tions between the hypothalamus, limbic system, hippocampus, 
brainstem, and cerebellum. The olfactory system and cerebellum 
share the top of this neural hierarchy. The cerebellum functions as 
the key area of the brain involved in integration of somatosensory 
information. Indeed, all pieces of somatosensory information 
have well-defined efferent connections to the cerebellum with the 
exception of the olfactory bulb. However, it remains a mystery 
why the cerebellum is consistently activated in human imaging 
studies that use an olfactory stimulus (Mainland et  al., 2005). 
Moreover, the unknown pathway crosses over, e.g., lesions in the 
left cerebellum impair odor processing in the contralateral nostril 
(Mainland et al., 2005). Data based on changing odor intensity 
suggest that the intranasal trigeminal system may be responsible 
for odor-induced activation of the cerebellum (Iannilli et al., 2011).
Thus, we speculate that peripherally administered OT has 
behavioral effects by targeting OT receptors in the olfactory 
bulb and viscera. Exogenous OT need not cross the blood–brain 
barrier to engage central OT receptors and trigger OT neuro-
transmission. It needs to go only as far as the olfactory bulbs and 
visceral afferents. A pulse of OT, originating from the hypotha-
lamic neurohypophyseal system that might naturally occur with 
emotional and biological events, readies the POS and coordinates 
an unconscious visceral response. The viscero-sensory informa-
tion is integrated at the level of brain stem and stored in the cer-
ebellum creating an internal model of the emotional/biological 
experience. The POS is constantly monitoring, evaluating, and 
screening information from the outside world associated with the 
emotional and/or biological event. The influence of the olfactory 
system on the organization and expression of behavior in animals 
is paramount and its effect on human behavior should not be 
under estimated.
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